Clinical Research Directory

Inclusion Criteria: * Age 0.5-18 years (except neonates). * Pathologically confirmed medulloblastoma. * Not having received any other relevant treatment before surgery. * Completion of enhanced MRI of the head and spinal cord. * Availability of tumor samples and determination of molecular typing. * Postoperative KPS score ≥ 70. * Voluntary enrollment in the group and the ability to receive long-term follow-up. * The patient or the patient's family voluntarily signed the informed consent form. Exclusion Criteria: * Patients who have recently received other drugs or radiation therapy. * Patients suffering from acute or chronic infectious diseases * Patients suffering from neurological or psychiatric diseases or mental disorders that cannot be easily controlled, or poor compliance. * Patients who cannot receive enhanced MRI scans. * Other conditions that the investigator believes make the patient unfit to participate in this trial.